Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
HGR's Cash to Debt is ranked lower than
56% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.21 vs. HGR: 0.01 )
HGR' s 10-Year Cash to Debt Range
Min: 0   Max: 0.86
Current: 0.01

0
0.86
Equity to Asset 0.44
HGR's Equity to Asset is ranked higher than
70% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HGR: 0.44 )
HGR' s 10-Year Equity to Asset Range
Min: 0.2   Max: 0.79
Current: 0.44

0.2
0.79
Interest Coverage 5.06
HGR's Interest Coverage is ranked higher than
68% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 5.75 vs. HGR: 5.06 )
HGR' s 10-Year Interest Coverage Range
Min: 0.43   Max: 13.53
Current: 5.06

0.43
13.53
F-Score: 4
Z-Score: 2.16
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 12.79
HGR's Operating margin (%) is ranked higher than
82% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 9.44 vs. HGR: 12.79 )
HGR' s 10-Year Operating margin (%) Range
Min: 2.59   Max: 15.73
Current: 12.79

2.59
15.73
Net-margin (%) 6.08
HGR's Net-margin (%) is ranked higher than
79% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. HGR: 6.08 )
HGR' s 10-Year Net-margin (%) Range
Min: -4.11   Max: 7.34
Current: 6.08

-4.11
7.34
ROE (%) 10.96
HGR's ROE (%) is ranked higher than
79% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 8.51 vs. HGR: 10.96 )
HGR' s 10-Year ROE (%) Range
Min: -15.39   Max: 14.06
Current: 10.96

-15.39
14.06
ROA (%) 5.00
HGR's ROA (%) is ranked higher than
79% of the 245 Companies
in the Global Medical Care industry.

( Industry Median: 3.63 vs. HGR: 5.00 )
HGR' s 10-Year ROA (%) Range
Min: -3.33   Max: 6.7
Current: 5

-3.33
6.7
ROC (Joel Greenblatt) (%) 33.46
HGR's ROC (Joel Greenblatt) (%) is ranked higher than
84% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 16.84 vs. HGR: 33.46 )
HGR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.65   Max: 51.39
Current: 33.46

8.65
51.39
Revenue Growth (%) 6.00
HGR's Revenue Growth (%) is ranked higher than
72% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. HGR: 6.00 )
HGR' s 10-Year Revenue Growth (%) Range
Min: -7.3   Max: 38.3
Current: 6

-7.3
38.3
EBITDA Growth (%) 21.90
HGR's EBITDA Growth (%) is ranked higher than
92% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. HGR: 21.90 )
HGR' s 10-Year EBITDA Growth (%) Range
Min: -24.7   Max: 51.5
Current: 21.9

-24.7
51.5
EPS Growth (%) 41.20
HGR's EPS Growth (%) is ranked higher than
93% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 11.70 vs. HGR: 41.20 )
HGR' s 10-Year EPS Growth (%) Range
Min: -21.1   Max: 44.2
Current: 41.2

-21.1
44.2
» HGR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

HGR Guru Trades in Q3 2013

HOTCHKIS & WILEY 352,100 sh (New)
Paul Tudor Jones 17,900 sh (+141.89%)
Joel Greenblatt 28,084 sh (+50.97%)
John Keeley 1,417,335 sh (+2.79%)
Jim Simons Sold Out
» More
Q4 2013

HGR Guru Trades in Q4 2013

HOTCHKIS & WILEY 458,700 sh (+30.28%)
John Keeley 1,619,225 sh (+14.24%)
Joel Greenblatt 28,859 sh (+2.76%)
Paul Tudor Jones Sold Out
» More
Q1 2014

HGR Guru Trades in Q1 2014

Jim Simons 25,400 sh (New)
Joel Greenblatt 197,842 sh (+585.55%)
HOTCHKIS & WILEY 756,400 sh (+64.9%)
John Keeley 1,616,914 sh (-0.14%)
» More
Q2 2014

HGR Guru Trades in Q2 2014

Paul Tudor Jones 8,400 sh (New)
HOTCHKIS & WILEY 874,600 sh (+15.63%)
Joel Greenblatt Sold Out
Jim Simons Sold Out
John Keeley 1,541,874 sh (-4.64%)
» More
» Details

Insider Trades

Latest Guru Trades with HGR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-06-30 Sold Out 0.1%$29.01 - $35.12 $ 22.4-30%0
Joel Greenblatt 2014-03-31 Add 585.55%0.09%$32.25 - $40.47 $ 22.4-38%197842
John Keeley 2013-12-31 Add 14.24%0.14%$32.79 - $39.58 $ 22.4-39%1619225
Joel Greenblatt 2013-09-30 Add 50.97%0.01%$30.46 - $36.92 $ 22.4-33%28084
Joel Greenblatt 2012-12-31 New Buy0.03%$22.74 - $28.45 $ 22.4-14%18392
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 13.60
HGR's P/E(ttm) is ranked higher than
96% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 41.40 vs. HGR: 13.60 )
HGR' s 10-Year P/E(ttm) Range
Min: 9.71   Max: 253.33
Current: 13.6

9.71
253.33
P/B 1.30
HGR's P/B is ranked higher than
90% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 3.10 vs. HGR: 1.30 )
HGR' s 10-Year P/B Range
Min: 0.51   Max: 2.59
Current: 1.3

0.51
2.59
P/S 0.75
HGR's P/S is ranked higher than
81% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.60 vs. HGR: 0.75 )
HGR' s 10-Year P/S Range
Min: 0.18   Max: 1.36
Current: 0.75

0.18
1.36
PFCF 86.15
HGR's PFCF is ranked higher than
55% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 39.53 vs. HGR: 86.15 )
HGR' s 10-Year PFCF Range
Min: 2.91   Max: 124.92
Current: 86.15

2.91
124.92
EV-to-EBIT 11.07
HGR's EV-to-EBIT is ranked higher than
95% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 26.63 vs. HGR: 11.07 )
HGR' s 10-Year EV-to-EBIT Range
Min: 7.3   Max: 52.2
Current: 11.07

7.3
52.2
PEG 1.01
HGR's PEG is ranked higher than
98% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HGR: 1.01 )
HGR' s 10-Year PEG Range
Min: 0.49   Max: 100.27
Current: 1.01

0.49
100.27
Shiller P/E 15.93
HGR's Shiller P/E is ranked higher than
94% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 353.47 vs. HGR: 15.93 )
HGR' s 10-Year Shiller P/E Range
Min: 15.2   Max: 588
Current: 15.93

15.2
588
Current Ratio 3.94
HGR's Current Ratio is ranked higher than
96% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.53 vs. HGR: 3.94 )
HGR' s 10-Year Current Ratio Range
Min: 0.44   Max: 8.75
Current: 3.94

0.44
8.75
Quick Ratio 2.45
HGR's Quick Ratio is ranked higher than
93% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. HGR: 2.45 )
HGR' s 10-Year Quick Ratio Range
Min: 0.3   Max: 7.98
Current: 2.45

0.3
7.98

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.90
HGR's Price/DCF (Projected) is ranked higher than
93% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 3.48 vs. HGR: 0.90 )
HGR' s 10-Year Price/DCF (Projected) Range
Min: 0.33   Max: 2.49
Current: 0.9

0.33
2.49
Price/Median PS Value 1.16
HGR's Price/Median PS Value is ranked higher than
77% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. HGR: 1.16 )
HGR' s 10-Year Price/Median PS Value Range
Min: 0.08   Max: 3.45
Current: 1.16

0.08
3.45
Price/Peter Lynch Fair Value 1.11
HGR's Price/Peter Lynch Fair Value is ranked higher than
96% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HGR: 1.11 )
HGR' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.51   Max: 21.7
Current: 1.11

0.51
21.7
Earnings Yield (Greenblatt) 9.00
HGR's Earnings Yield (Greenblatt) is ranked higher than
90% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 5.20 vs. HGR: 9.00 )
HGR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.9   Max: 13.7
Current: 9

1.9
13.7
Forward Rate of Return (Yacktman) 16.93
HGR's Forward Rate of Return (Yacktman) is ranked higher than
86% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 10.64 vs. HGR: 16.93 )
HGR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -947.7   Max: 35.8
Current: 16.93

-947.7
35.8

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:HO8.Germany
Hanger Inc is a provider of services and products that enhance human physical capabilities. The Company provides orthotic and prosthetic patient-care services, distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to the broader post acute market. It operates in excess of 700 O&P patient-care centers located in 45 states and the District of Columbia and six strategically located distribution facilities. In addition to providing O&P services and products, through its subsidiary, Linkia LLC ('Linkia'), it manages an O&P network and develops programs to manage all aspects of O&P patient-care for insurance companies. It provides therapeutic solutions through subsidiaries Innovative Neurotronics and Accelerated Care Plus Corp. Innovative Neurotronics ('IN, Inc.') introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers. Accelerated Care Plus Corp. ('ACP') is a developer of specialized rehabilitation technologies and a provider of evidence-based clinical programs for post-acute rehabilitation serving more than 4,000 long-term care facilities and other sub-acute rehabilitation providers throughout the U.S. Its operations include three reportable segments—Patient-Care Services, Distribution, and Therapeutic Solutions. Patient-Care Services: Patients are referred to its local patient-care centers directly by physicians as a result of reputation with them or through agreements with managed care providers; Distribution Services: It distributes O&P components to its customers and to its own patient-care centers through wholly-owned subsidiary. It is also a manufacturer and distributor of therapeutic footwear for diabetic patients in the podiatric market; and Therapeutic Solutions: It provides therapeutic solutions to the O&P market and post-acute rehabilitation market through subsidiaries IN, Inc. and ACP. On December 1, 2010 it acquired ACP, which is the nation's provider of rehabilitation technologies and integrated clinical programs to rehabilitation providers.
» More Articles for HGR

Headlines

Articles On GuruFocus.com
Hanger: A favorable aging demography trend Aug 14 2014 
Hanger Orthopedic Group Inc. Reports Operating Results (10-K) Mar 11 2011 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 26,000 Sh Feb 28 2011 
John Keeley Buys CAR, HGR, NCR, DAN, SKS, FELE, NWBI, FII, MF, HHC Feb 09 2011 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 30,000 Sh Nov 22 2010 
Hanger Orthopedic Group Inc. (HGR) President and CEO Thomas F Kirk sells 10,030 Shares Nov 18 2010 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 1,525 Sha Nov 18 2010 
Hanger Orthopedic Group Inc. (HGR) President and CEO Thomas F Kirk sells 11,458 Shares Aug 13 2010 
Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 3,348 Sha Aug 13 2010 
Hanger Orthopedic Group Inc. (HGR) Chairman of the Board Ivan R Sabel sells 56,798 Shares Jul 06 2010 


More From Other Websites
NYSE stocks posting largest percentage increases Aug 29 2014
Insider Trading Alert - RSG, HGR And URI Traded By Insiders Aug 27 2014
MedTech Defies Sequestration, M&As Steal the Show Aug 26 2014
HANGER, INC. Financials Aug 19 2014
Asif Ahmad, Chief Executive Officer and Board Member of Anthelio Healthcare Solutions, Named to... Aug 14 2014
HANGER, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Aug 13 2014
Hanger Announces Appointment of Asif Ahmad to Board of Directors Aug 13 2014
HANGER, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
Hanger Misses on Q2 Earnings and Revenues, Trims Guidance Aug 08 2014
Why Hanger (HGR) Stock Is Falling Today Aug 08 2014
Hanger Inc Earnings Call scheduled for 9:00 am ET today Aug 08 2014
HANGER, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 08 2014
Hanger Reports Second Quarter 2014 Financial Results Aug 07 2014
Q2 2014 Hanger Earnings Release - After Market Close Aug 07 2014
Hanger Reschedules Second Quarter 2014 Earnings Release and Conference Call Aug 05 2014
Q2 2014 Hanger Earnings Release - After Market Close Aug 05 2014
Christopher J. Reading, the President and CEO of U.S. Physical Therapy, Inc. (USPH), Interviews with... Aug 04 2014
A Wall Street Transcript Interview with Dana Hambly, CFA, Research Associate on the Health Care... Aug 01 2014
Hanger to Release Second Quarter 2014 Results on Tuesday, August 5 After Market Close and Host... Jul 18 2014
Stability And Growth Of Hanger's Cash Flows Provide For A Sound Investment Jul 12 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK